2022 annual financial data
BioRestorative Therapies 2022 Net margin
Direct answer
Net margin was -11,036.97%.
Operating income was -18,863,507 USD and net income was -13,222,296 USD.
Operating cash flow was -5,913,100 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 119,800 USD
- Operating income
- -18,863,507 USD
- Net income
- -13,222,296 USD
- Operating cash flow
- -5,913,100 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all BioRestorative Therapies financial years